by Cellenkos Inc.
Physician-investigators at Johns Hopkins University Hospital report on the promising data of treatment of COVID-19 induced acute respiratory distress syndrome with allogeneic, cord blood derived T-regulatory (Treg) cell therapy (manufactured by Cellenkos®), published in peer reviewed journal of Annals of Internal Medicine.
by Covalent Metrology
The introduction of two cutting-edge dual-beam focused ion beam scanning electron (FIB-SEM) microscopes at Covalent’s Sunnyvale, CA headquarters will provide clients faster, deeper, and more advanced analytical capabilities.
by Sorrel Medical
Sorrel Medical, a developer and manufacturer of wearable drug delivery devices, today announced the opening of a new manufacturing facility with state-of-the-art cleanroom facilities to accommodate manufacturing scalability of its wearable drug delivery devices.
by ANDREW MYERS | Stanford University
A Stanford-led team has invented a way to store data by sliding atomically thin layers of metal over one another, an approach that could pack more data into less space than silicon chips, while also using less energy.
by Grand River Aseptic Manufacturing
Grand River Aseptic Manufacturing (“GRAM”), an agile and modern parenteral contract development and manufacturing organization (CDMO), completed its major $60 million expansion project and recently took occupancy.
by Coveris Management GmbH
In line with the increased focus on the medical market segment, Coveris is taking a gigantic leap forward to modernize their medical packaging production facilities. With an extensive EUR 10 m investment program, Coveris strives to become best in class when it comes to process transparency, cleanliness and quality.
by Sexton Biotechnologie
Sexton Biotechnologies has announced a new collaboration with BioSpherix Medical. As a tool and technologies partners of the Cell and Gene industry, Sexton and BioSpherix both recognize the need for cost-effective and flexible automation solutions during cell and gene therapy process development. While some upstream bioprocesses have been successfully automated, the final steps of downstream bioprocess, namely Fill-Finish, are often done manually with associated risks of contamination and user error.
by Integrity Cleanroom
Integrity Cleanroom is pleased to announce that it has begun commercial transactions with a brand new ecommerce platform and a dedicated team of professionals based in Texas.
by New York State Preferred Source Program for New Yorkers Who Are Blind (NYSPSP)
The New York State Preferred Source Program for New Yorkers Who Are Blind (NYSPSP) continues to play a significant role in coordinating a strategic statewide response among its network of 10 affiliated nonprofit agencies, many of whom are providing essential products and services to help New York fight COVID-19.
by RESET®
Working with an international team of experts from universities on the forefront of air quality monitoring research, RESET® will be releasing a new air quality standard aimed at providing a framework for qualifying airborne particulate sensors – specifically optical particle counters – used for indoor and outdoor air quality monitoring.
by Linked Enterprises
Together these five companies have put together complex build solutions in response to the coronavirus. Individually they were the best for being the fastest of their building type, together they provide the complete solution within weeks, regardless of the requirements. RPM acts as the quarterback pulling in a team of top North American manufacturers with the specific purpose of delivering rapid deployment Community Response Facilities (CRF) that are designed to meet each community’s critical needs. If the location requires conversion of an existing structure, a large building shell that goes up quickly, or mobile secure steel buildings, together we have it covered.
by Germfree Laboratories, Inc.
Germfree delivered a 53-foot biocontainment cleanroom trailer to a major US pharmaceutical company where they will work on a COVID-19 vaccine. This is the first, of what is expected to be, many mobile laboratory spaces that will be delivered to scientists and organizations working on virus and antibody testing, vaccine development, research, and deployment solutions.